Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration.
<h4>Background</h4>Dialysis patients have an increased risk of mortality. Recently treatment with haemodiafiltration (HDF) has been reported to reduce mortality, particularly cardiovascular mortality, compared to standard high-flux haemodialysis (HD). However, why HDF may offer a surviva...
Guardado en:
Autores principales: | Arkom Nongnuch, Chagriya Kitiyakara, Supawadee Sappadungsuk, Nuankanya Sathirapongsasuti, Kotcharat Vipattawat, Pin Zhang, Nathan Davies, Andrew Davenport |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/500501fc4ddd4a98a4fbf41645f24314 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia
por: Emma Martínez-Alonso, et al.
Publicado: (2020) -
Serum sodium variation is a major determinant of peridialytic blood pressure trends in haemodialysis outpatients
por: David A. Jaques, et al.
Publicado: (2021) -
PREDICTING QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS
por: Abdul Rehman Arshad, et al.
Publicado: (2019) -
Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?
por: Laura E A Harrison, et al.
Publicado: (2012) -
Cognitive impairment is associated with mitochondrial dysfunction in peripheral blood mononuclear cells of elderly population
por: Nattayaporn Apaijai, et al.
Publicado: (2020)